Biogen (NASDAQ:BIIB) and Stoke Therapeutics (NASDAQ:STOK) said on Tuesday they are collaborating to develop and commercialize ...

Sales of an Alzheimer’s disease treatment were better than expected, but that and a quarterly beat wasn’t enough to offset below-consensus EPS outlook.

Ottawa enzyme maker Iogen Corp. and fuel company Shell have agreed to speed up their joint-venture work on cellulosic ethanol made from wheat straw, using “significant” extra funding from Shell. The ...